×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Iovance Biotherapeutics Inc. (IOVA) NASDAQ

$8.01 0.04 (0.50%)

Market Cap: $2.24B

As of 06/21/24 04:00 PM EDT. Market closed.

(IOVA)

Iovance Biotherapeutics Inc. (IOVA)
NASDAQ

$8.01
0.04 (0.50%)

Market Cap: $2.24B

As of 06/21/24 04:00 PM EDT. Market closed.

Add to Portfolio

iovance biotherapeutics is focused on the development and commercialization of novel cancer immunotherapies based on tumor infiltrating lymphocytes (til). this approach, also known as adoptive t-cell therapy, was initially developed by dr. steven a. rosenberg at the national cancer institute (nci). in phase 2 clinical trials conducted at the nci, 56% and 24% of patients treated with this ... read more

COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$600,000
CEO Compensation (Total)
$9.39M
URL
Address
.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO Compensation (Base)
$600,000
CEO Compensation (Total)
$9.39M
Address
.
PRICE CHART FOR IOVANCE BIOTHERAPEUTICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$8.10
Previous Close
$7.97
Days Range
$7.88 - $8.12
52 week range
$3.21 - $18.33
Volume
11,295,026
Avg. Volume (30 days)
7,799,531
Market Cap
$2.24B
Dividend Yield
-
P/E
-
Shares Outstanding
279,832,722
Open
$8.10
Previous Close
$7.97
Days Range
$7.88 - $8.12
52 week range
$3.21 - $18.33
Volume
11,295,026
Avg. Volume (30 days)
7,799,531
Market Cap
$2.24B
Dividend Yield
-
P/E
-
Shares Outstanding
279,832,722
FINANCIAL STATEMENTS FOR IOVANCE BIOTHERAPEUTICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR IOVANCE BIOTHERAPEUTICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerJun 03, 2024 Option Exercise$8.371,98216,58944,486Jun 05, 2024, 08:07 PM
BILINSKY IGORChief Operating OfficerJun 03, 2024 Option Exercise$8.371,78414,93239,758Jun 05, 2024, 08:05 PM
Vogt Frederick GInterim CEO & General CounselJun 03, 2024 Option Exercise$8.374,42637,046147,325Jun 05, 2024, 08:04 PM
Vogt Frederick GInterim CEO & General CounselApr 15, 2024 Option Exercise$11.898,851105,238141,334Apr 17, 2024, 07:08 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerApr 15, 2024 Option Exercise$11.891,42716,96742,562Apr 17, 2024, 07:07 PM
BILINSKY IGORChief Operating OfficerApr 15, 2024 Option Exercise$11.891,42716,96738,026Apr 17, 2024, 07:07 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerMar 04, 2024 Option Exercise$16.968,053136,57941,177Mar 06, 2024, 06:20 PM
Vogt Frederick GInterim CEO & General CounselMar 04, 2024 Option Exercise$16.9611,449194,175129,351Mar 06, 2024, 06:19 PM
BILINSKY IGORChief Operating OfficerMar 04, 2024 Option Exercise$16.967,287123,58836,641Mar 06, 2024, 06:17 PM
MCPEAK MERRILL ADirectorFeb 20, 2024 Buy$9.15250,0002,287,500320,150Feb 20, 2024, 07:52 PM
Dukes Iain D.DirectorFeb 20, 2024 Buy$9.1532,000292,80054,000Feb 20, 2024, 04:21 PM
Rothbaum Wayne P.DirectorFeb 20, 2024 Buy$9.155,000,00045,749,99828,067,333Feb 20, 2024, 04:11 PM
Vogt Frederick GInterim CEO & General CounselJan 16, 2024 Option Exercise$8.376,53054,65699,138Jan 18, 2024, 06:09 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerJan 16, 2024 Option Exercise$8.371,57713,19933,607Jan 18, 2024, 06:09 PM
BILINSKY IGORChief Operating OfficerJan 16, 2024 Option Exercise$8.371,57713,19929,867Jan 18, 2024, 06:07 PM
Vogt Frederick GInterim CEO & General CounselOct 16, 2023 Option Exercise$3.578,85131,59884,834Oct 18, 2023, 08:05 PM
BILINSKY IGORChief Operating OfficerOct 16, 2023 Option Exercise$3.571,3954,98028,631Oct 18, 2023, 08:04 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerOct 16, 2023 Option Exercise$3.571,3954,98032,371Oct 18, 2023, 08:03 PM
MCPEAK MERRILL ADirectorSep 18, 2023 Buy$5.5610,00055,600248,633Sep 19, 2023, 04:30 PM
Rothbaum Wayne P.DirectorSep 15, 2023 Buy$5.305,000,00026,500,00123,067,333Sep 15, 2023, 06:12 PM
Vogt Frederick GInterim CEO & General CounselJul 14, 2023 Option Exercise$7.768,85168,68472,850Jul 17, 2023, 06:22 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerJul 14, 2023 Option Exercise$7.761,39510,82530,953Jul 17, 2023, 06:22 PM
BILINSKY IGORChief Operating OfficerJul 14, 2023 Option Exercise$7.761,39510,82527,213Jul 17, 2023, 06:21 PM
Vogt Frederick GInterim CEO & General CounselApr 14, 2023 Option Exercise$5.648,85149,92060,867Apr 18, 2023, 05:50 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerApr 14, 2023 Option Exercise$5.641,3957,86829,535Apr 18, 2023, 05:49 PM
BILINSKY IGORChief Operating OfficerApr 14, 2023 Option Exercise$5.641,3957,86825,795Apr 18, 2023, 05:48 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerJan 17, 2023 Option Exercise$6.434,67830,08028,118Jan 19, 2023, 04:52 PM
BILINSKY IGORChief Operating OfficerJan 17, 2023 Option Exercise$6.434,67130,03524,378Jan 19, 2023, 04:52 PM
Vogt Frederick GInterim CEO & General CounselJan 17, 2023 Option Exercise$6.4336,441234,31648,884Jan 19, 2023, 04:51 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerJan 03, 2023 Option Exercise$6.1111,02367,35121,548Jan 05, 2023, 08:57 PM
BILINSKY IGORChief Operating OfficerJan 03, 2023 Option Exercise$6.1110,55364,47917,801Jan 05, 2023, 08:45 PM
Bellemin Jean-MarcChief Financial OfficerJan 03, 2023 Option Exercise$6.1110,55364,47917,801Jan 05, 2023, 08:45 PM
MCPEAK MERRILL ADirectorDec 21, 2022 Buy$6.1510,00061,50070,150Dec 22, 2022, 04:06 PM
Rothbaum Wayne P.DirectorDec 02, 2022 Buy$6.5010,000,00065,000,00018,067,333Dec 02, 2022, 05:29 PM
MCPEAK MERRILL ADirectorNov 29, 2022 Buy$6.3110,00063,100238,633Nov 30, 2022, 04:17 PM
Vogt Frederick GInterim CEO & General CounselNov 28, 2022 Buy$5.981,0005,9802,000Nov 28, 2022, 09:46 PM
MCPEAK MERRILL ADirectorNov 28, 2022 Buy$6.1810,00061,800228,633Nov 28, 2022, 09:44 PM
Dukes Iain D.DirectorNov 23, 2022 Buy$6.1010,00061,00022,000Nov 28, 2022, 09:43 PM
MCPEAK MERRILL ADirectorAug 23, 2022 Option Exercise$5.6540,000226,00060,150Aug 25, 2022, 04:15 PM
GRAF FINCKENSTEIN FRIEDRICHChief Medical OfficerJun 14, 2022 Option Exercise$7.736,80952,63412,881Jun 16, 2022, 05:04 PM
Bellemin Jean-MarcChief Financial OfficerJun 14, 2022 Option Exercise$7.739,34672,2459,504Jun 16, 2022, 05:03 PM
BILINSKY IGORChief Operating OfficerJun 14, 2022 Option Exercise$7.739,34672,2459,504Jun 16, 2022, 05:03 PM
MCPEAK MERRILL ADirectorMay 31, 2022 Buy$6.8410,00068,40020,150Jun 02, 2022, 08:03 PM
MCPEAK MERRILL ADirectorMay 31, 2022 Buy$6.8010,00068,000218,633Jun 02, 2022, 08:03 PM
Maynard Ryan DDirectorMay 31, 2022 Buy$6.747,50050,5877,500Jun 02, 2022, 08:02 PM
WEISER MICHAELDirectorMay 31, 2022 Buy$6.8010,00067,978112,632Jun 02, 2022, 08:01 PM
Vogt Frederick GInterim CEO & General CounselJun 01, 2022 Buy$6.441,0006,4401,000Jun 02, 2022, 08:00 PM
Rothbaum Wayne P.DirectorJun 01, 2022 Buy$6.43500,0003,215,5008,067,333Jun 02, 2022, 07:59 PM
Rothbaum Wayne P.DirectorMay 31, 2022 Buy$6.77500,0003,384,5507,567,333Jun 02, 2022, 07:59 PM
Fardis MariaPresident and CEOJun 01, 2020 Option Exercise$33.121,89462,729298,786Jun 02, 2020, 07:19 PM
Fardis MariaPresident and CEOMay 01, 2020 Option Exercise$32.001,89460,608300,680May 04, 2020, 09:01 PM
Fardis MariaPresident and CEOApr 01, 2020 Option Exercise$27.941,49441,742302,574Apr 03, 2020, 04:30 PM
Fardis MariaPresident and CEOMar 02, 2020 Option Exercise$35.991,32147,543304,068Mar 04, 2020, 05:00 PM
Fardis MariaPresident and CEOFeb 03, 2020 Option Exercise$22.541,30229,347305,389Feb 05, 2020, 04:31 PM
Fardis MariaPresident and CEOJan 02, 2020 Option Exercise$26.681,56241,674306,691Jan 06, 2020, 07:00 PM
Fardis MariaPresident and CEODec 02, 2019 Option Exercise$22.661,89442,918308,253Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEONov 01, 2019 Option Exercise$21.971,89441,611310,147Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJul 01, 2017 Option Exercise$7.351,99414,656352,837Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOFeb 01, 2019 Option Exercise$9.261,56214,464323,448Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJan 01, 2018 Option Exercise$8.001,56212,496341,307Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOAug 01, 2019 Option Exercise$25.171,32133,250315,545Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJul 01, 2018 Option Exercise$12.801,32116,909333,177Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJun 01, 2017 Option Exercise$5.45143,496782,053354,831Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJan 02, 2019 Option Exercise$9.451,56214,761325,010Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEODec 01, 2017 Option Exercise$8.801,99417,547342,869Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJul 01, 2019 Option Exercise$24.621,32132,523316,866Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJun 01, 2018 Option Exercise$14.551,32119,221334,498Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOApr 03, 2017 Option Exercise$7.1551,673369,462498,327Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEODec 01, 2018 Option Exercise$10.441,32113,791326,572Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEONov 01, 2017 Option Exercise$7.151,99414,257344,863Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOJun 03, 2019 Option Exercise$18.041,32123,831318,187Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOMay 01, 2018 Option Exercise$14.601,32119,287335,819Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEONov 01, 2018 Option Exercise$9.621,32112,708327,893Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOOct 01, 2017 Option Exercise$7.751,99315,446346,857Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOMay 01, 2019 Option Exercise$11.141,32114,716319,508Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOApr 01, 2018 Option Exercise$16.901,32122,325337,140Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOOct 01, 2018 Option Exercise$11.121,32114,690329,214Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOSep 01, 2017 Option Exercise$6.001,99411,964348,850Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOApr 01, 2019 Option Exercise$9.781,32112,919320,829Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOMar 01, 2018 Option Exercise$18.151,32123,976338,461Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOOct 01, 2019 Option Exercise$18.211,89434,490312,041Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOSep 04, 2018 Option Exercise$17.101,32122,589330,535Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOAug 01, 2017 Option Exercise$5.701,99311,360350,844Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOMar 01, 2019 Option Exercise$10.771,29813,979322,150Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOFeb 01, 2018 Option Exercise$16.501,52525,163339,782Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOSep 03, 2019 Option Exercise$20.271,61032,635313,935Dec 04, 2019, 09:01 PM
Fardis MariaPresident and CEOAug 01, 2018 Option Exercise$13.701,32118,098331,856Dec 04, 2019, 09:01 PM
Dukes Iain D.DirectorDec 18, 2018 Buy$8.6512,000103,79612,000Dec 20, 2018, 05:00 PM
MCPEAK MERRILL ADirectorDec 13, 2018 Buy$9.6310,00096,273456,583Dec 14, 2018, 05:00 PM
Rothbaum Wayne P.DirectorDec 06, 2018 Buy$9.86300,0002,958,0007,067,333Dec 07, 2018, 04:32 PM
Rothbaum Wayne P.DirectorDec 04, 2018 Buy$10.31921,0539,496,0576,767,333Dec 07, 2018, 04:32 PM
Hillsberg SanfordDirectorAug 25, 2016 Sale$8.7120,500178,612100,000Aug 26, 2016, 03:49 PM
Hillsberg SanfordDirectorAug 24, 2016 Sale$9.1033,500304,800120,500Aug 26, 2016, 03:49 PM
Hillsberg SanfordDirectorAug 22, 2016 Sale$9.1154,000491,740100,000Aug 24, 2016, 02:18 PM
HAWKINS ELMAPresident and CEOFeb 28, 2015 Option Exercise$8.9823,988215,412176,567Dec 30, 2015, 06:57 PM
Bender James G.Vice President, ManufacturingSep 30, 2015 Option Exercise$5.7611,27464,93888,726Dec 30, 2015, 03:00 PM
Hillsberg SanfordDirectorSep 08, 2015 Sale$7.1316,500117,645154,000Sep 09, 2015, 01:13 PM
Hillsberg SanfordDirectorSep 04, 2015 Sale$6.8416,000109,440170,500Sep 09, 2015, 01:13 PM
Hillsberg SanfordDirectorAug 03, 2015 Sale$8.1532,500264,875186,500Aug 04, 2015, 05:05 PM
Ayer Capital Management, LP10% OwnerMay 01, 2015 Sale$9.622,780,68226,752,3852,823,333May 08, 2015, 01:07 PM
Hillsberg SanfordDirectorMay 06, 2015 Sale$10.0050,000500,000219,000May 07, 2015, 05:49 PM
BRISTOL INVESTMENT FUND LTD10% OwnerNov 06, 2014 Sale$690000.00100,00069,000,000,0003,867,863Nov 07, 2014, 08:41 AM
Ayer Capital Management, LPDirectorMay 22, 2013 Option Exercise$0.05560,088,65027,444,343560,401,150Jul 23, 2014, 06:38 AM
MCPEAK MERRILL A/DirectorNov 05, 2013 Buy$2.0050,000100,000396,432Nov 12, 2013, 04:48 PM
Singh ManishPresident & CEONov 05, 2013 Buy$2.00125,000250,0001,938,500Nov 07, 2013, 08:20 PM
BRISTOL INVESTMENT FUND LTD10% OwnerMay 22, 2013 Option Exercise$3564770.00389,849,5871,389,724,112,249,990399,873,215Jun 04, 2013, 03:17 PM
VOYTICKY DAVID JDirectorMay 22, 2013 Option Exercise$0.015,677,86756,7795,627,867May 30, 2013, 09:19 PM
MCPEAK MERRILL A/Interim President and CEOMay 22, 2013 Option Exercise$0.0121,280,000212,80021,290,000May 30, 2013, 08:50 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer06/03/202416,589
BILINSKY IGORChief Operating Officer06/03/202414,932
Vogt Frederick GInterim CEO & General Counsel06/03/202437,046
Vogt Frederick GInterim CEO & General Counsel04/15/2024105,238
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer04/15/202416,967
BILINSKY IGORChief Operating Officer04/15/202416,967
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer03/04/2024136,579
Vogt Frederick GInterim CEO & General Counsel03/04/2024194,175
BILINSKY IGORChief Operating Officer03/04/2024123,588
MCPEAK MERRILL ADirector02/20/20242,287,500
Dukes Iain D.Director02/20/2024292,800
Rothbaum Wayne P.Director02/20/202445,749,998
Vogt Frederick GInterim CEO & General Counsel01/16/202454,656
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer01/16/202413,199
BILINSKY IGORChief Operating Officer01/16/202413,199
Vogt Frederick GInterim CEO & General Counsel10/16/202331,598
BILINSKY IGORChief Operating Officer10/16/20234,980
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer10/16/20234,980
MCPEAK MERRILL ADirector09/18/202355,600
Rothbaum Wayne P.Director09/15/202326,500,001
Vogt Frederick GInterim CEO & General Counsel07/14/202368,684
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer07/14/202310,825
BILINSKY IGORChief Operating Officer07/14/202310,825
Vogt Frederick GInterim CEO & General Counsel04/14/202349,920
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer04/14/20237,868
BILINSKY IGORChief Operating Officer04/14/20237,868
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer01/17/202330,080
BILINSKY IGORChief Operating Officer01/17/202330,035
Vogt Frederick GInterim CEO & General Counsel01/17/2023234,316
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer01/03/202367,351
BILINSKY IGORChief Operating Officer01/03/202364,479
Bellemin Jean-MarcChief Financial Officer01/03/202364,479
MCPEAK MERRILL ADirector12/21/202261,500
Rothbaum Wayne P.Director12/02/202265,000,000
MCPEAK MERRILL ADirector11/29/202263,100
Vogt Frederick GInterim CEO & General Counsel11/28/20225,980
MCPEAK MERRILL ADirector11/28/202261,800
Dukes Iain D.Director11/23/202261,000
MCPEAK MERRILL ADirector08/23/2022226,000
GRAF FINCKENSTEIN FRIEDRICHChief Medical Officer06/14/202252,634
Bellemin Jean-MarcChief Financial Officer06/14/202272,245
BILINSKY IGORChief Operating Officer06/14/202272,245
MCPEAK MERRILL ADirector05/31/202268,400
MCPEAK MERRILL ADirector05/31/202268,000
Maynard Ryan DDirector05/31/202250,587
WEISER MICHAELDirector05/31/202267,978
Vogt Frederick GInterim CEO & General Counsel06/01/20226,440
Rothbaum Wayne P.Director06/01/20223,215,500
Rothbaum Wayne P.Director05/31/20223,384,550
Fardis MariaPresident and CEO06/01/202062,729
Fardis MariaPresident and CEO05/01/202060,608
Fardis MariaPresident and CEO04/01/202041,742
Fardis MariaPresident and CEO03/02/202047,543
Fardis MariaPresident and CEO02/03/202029,347
Fardis MariaPresident and CEO01/02/202041,674
Fardis MariaPresident and CEO12/02/201942,918
Fardis MariaPresident and CEO11/01/201941,611
Fardis MariaPresident and CEO07/01/201714,656
Fardis MariaPresident and CEO02/01/201914,464
Fardis MariaPresident and CEO01/01/201812,496
Fardis MariaPresident and CEO08/01/201933,250
Fardis MariaPresident and CEO07/01/201816,909
Fardis MariaPresident and CEO06/01/2017782,053
Fardis MariaPresident and CEO01/02/201914,761
Fardis MariaPresident and CEO12/01/201717,547
Fardis MariaPresident and CEO07/01/201932,523
Fardis MariaPresident and CEO06/01/201819,221
Fardis MariaPresident and CEO04/03/2017369,462
Fardis MariaPresident and CEO12/01/201813,791
Fardis MariaPresident and CEO11/01/201714,257
Fardis MariaPresident and CEO06/03/201923,831
Fardis MariaPresident and CEO05/01/201819,287
Fardis MariaPresident and CEO11/01/201812,708
Fardis MariaPresident and CEO10/01/201715,446
Fardis MariaPresident and CEO05/01/201914,716
Fardis MariaPresident and CEO04/01/201822,325
Fardis MariaPresident and CEO10/01/201814,690
Fardis MariaPresident and CEO09/01/201711,964
Fardis MariaPresident and CEO04/01/201912,919
Fardis MariaPresident and CEO03/01/201823,976
Fardis MariaPresident and CEO10/01/201934,490
Fardis MariaPresident and CEO09/04/201822,589
Fardis MariaPresident and CEO08/01/201711,360
Fardis MariaPresident and CEO03/01/201913,979
Fardis MariaPresident and CEO02/01/201825,163
Fardis MariaPresident and CEO09/03/201932,635
Fardis MariaPresident and CEO08/01/201818,098
Dukes Iain D.Director12/18/2018103,796
MCPEAK MERRILL ADirector12/13/201896,273
Rothbaum Wayne P.Director12/06/20182,958,000
Rothbaum Wayne P.Director12/04/20189,496,057
Hillsberg SanfordDirector08/25/2016178,612
Hillsberg SanfordDirector08/24/2016304,800
Hillsberg SanfordDirector08/22/2016491,740
HAWKINS ELMAPresident and CEO02/28/2015215,412
Bender James G.Vice President, Manufacturing09/30/201564,938
Hillsberg SanfordDirector09/08/2015117,645
Hillsberg SanfordDirector09/04/2015109,440
Hillsberg SanfordDirector08/03/2015264,875
Ayer Capital Management, LP10% Owner05/01/201526,752,385
Hillsberg SanfordDirector05/06/2015500,000
BRISTOL INVESTMENT FUND LTD10% Owner11/06/201469,000,000,000
Ayer Capital Management, LPDirector05/22/201327,444,343
MCPEAK MERRILL A/Director11/05/2013100,000
Singh ManishPresident & CEO11/05/2013250,000
BRISTOL INVESTMENT FUND LTD10% Owner05/22/20131,389,724,112,249,990
VOYTICKY DAVID JDirector05/22/201356,779
MCPEAK MERRILL A/Interim President and CEO05/22/2013212,800
Load More Insider Transactions
FUNDS WITH A POSITION IN IOVANCE BIOTHERAPEUTICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BLACKROCK INC.19,929,7020.00688%4.5%Other
GEODE CAPITAL MANAGEMENT, LLC5,506,6170.00755%9.32%Other
ORBIMED ADVISORS LLC4,707,4580.76%ExitedOther
BALYASNY ASSET MANAGEMENT L.P.1,200,8640.03%-69.41%Event Driven
D. E. SHAW & CO., INC.2,352,1660.03%993.35%Other
PALO ALTO INVESTORS LP2,112,8113.53%0.29%Other
CANDRIAM S.C.A.1,059,1420.1%-38.7%Other
VIVO CAPITAL, LLC655,0570.44%ExitedOther
DRIEHAUS CAPITAL MANAGEMENT LLC642,7610.09%NewGrowth
FARALLON CAPITAL MANAGEMENT LLC26,0000.00175%-95.37%Event Driven, Value
OCONNOR, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS (LLC)40,000 (Call)0.00143%-87.88%Value
TUDOR INVESTMENT CORP ET AL244,6160.02%637.95%Event Driven, Other
UBS OCONNOR LLC104,0590.04%ExitedValue
D. E. SHAW & CO., INC.84,200 (Put)0.00107%NewOther
D. E. SHAW & CO., INC.69,400 (Call)0.00088%NewOther
AQR CAPITAL MANAGEMENT LLC40,0110.00099%NewOther
CHANGE IN SHARES OUTSTANDING FOR IOVANCE BIOTHERAPEUTICS INC
STOCK BUYBACKS FOR IOVANCE BIOTHERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2024
12/31/2023
3.92%
1Q
03/31/2024
09/30/2023
8.30%
2Q
03/31/2024
06/30/2023
18.59%
3Q
03/31/2024
03/31/2023
24.58%
4Q
03/31/2024
12/31/2022
61.52%
5Q
03/31/2024
09/30/2022
68.69%
6Q
03/31/2024
06/30/2022
69.27%
7Q
03/31/2024
03/31/2022
69.44%
8Q
03/31/2024
12/31/2021
69.61%
9Q
03/31/2024
09/30/2021
71.19%
10Q
03/31/2024
06/30/2021
73.15%
11Q
03/31/2024
03/31/2021
80.65%
12Q
03/31/2024
12/31/2020
81.31%
13Q
03/31/2024
09/30/2020
81.73%
14Q
Load More

Period of Report: 03/31/2024

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2023
3.92%
1Q
09/30/2023
8.30%
2Q
06/30/2023
18.59%
3Q
03/31/2023
24.58%
4Q
12/31/2022
61.52%
5Q
09/30/2022
68.69%
6Q
06/30/2022
69.27%
7Q
03/31/2022
69.44%
8Q
12/31/2021
69.61%
9Q
09/30/2021
71.19%
10Q
06/30/2021
73.15%
11Q
03/31/2021
80.65%
12Q
12/31/2020
81.31%
13Q
09/30/2020
81.73%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR IOVANCE BIOTHERAPEUTICS INC
LOADING...